Group B strep (GBS) is a bacterium that can be carried in the digestive tract, urinary tract, or genital area of healthy adults. It is passed from mother to baby during labor and delivery, primarily through contact with infected amniotic fluid or vaginal secretions. The bacteria do not spread through casual contact, food, or water.
GBS colonization occurs in about 25% of pregnant women, but most carriers show no symptoms. Transmission happens during vaginal birth when the baby passes through the birth canal. The risk increases if membranes rupture early or labor lasts longer than 18 hours. Antibiotics given during labor reduce transmission by 80% or more.
Transmission is not preventable by hygiene practices like handwashing or avoiding public places. The bacteria are part of normal flora in many people. Screening at 36 weeks gestation identifies carriers. Without treatment, 1 in 200 babies born to untreated mothers develop early-onset GBS disease.
During labor, the baby's skin and mucous membranes come into direct contact with the mother's vaginal and rectal areas. If she carries GBS, the bacteria can colonize the baby's mouth, nose, or throat within minutes of birth. The infant may then aspirate infected fluids during breathing, leading to pneumonia or sepsis.
Amniotic fluid contamination is another route. If the amniotic sac ruptures before labor begins, bacteria can ascend into the uterus. A study published in The New England Journal of Medicine found that 40% of GBS infections in newborns were linked to prolonged rupture of membranes (more than 18 hours).
Even if the mother shows no signs of infection-fever, chills, or pain-the baby can still be exposed. The absence of symptoms in the mother does not eliminate risk. This is why universal screening is recommended, regardless of clinical signs.
Carriage rates vary by population. In the United States, approximately 25% of pregnant women carry GBS in their rectum or vagina. Rates are higher among Black and Hispanic women compared to White women, according to CDC data from 2021.
Carriers are often unaware they have GBS. There are no standard symptoms. Some women report mild vaginal discharge or odor, but these are not diagnostic. The only way to know is through a swab test done between 35 and 37 weeks of pregnancy.
Once identified, intravenous antibiotics (usually penicillin) are administered during labor. This reduces the chance of transmission to less than 1%. Without treatment, the risk rises to 1-2% for early-onset disease. Early-onset GBS occurs within the first 7 days of life and can cause serious illness, including meningitis and bloodstream infections.
| Factor | Impact on GBS Transmission Risk |
|---|---|
| Antibiotic administration during labor | Reduces risk by 80-90% |
| Rupture of membranes >18 hours | Increases risk 2.5-fold |
| Preterm labor (<37 weeks) | Increases risk 3-fold |
| Maternal fever during labor | Increases risk 2-fold |
Many people believe GBS spreads through breastfeeding, kissing, or sharing utensils. This is false. GBS is not transmitted via saliva, breast milk, or casual contact. The bacteria do not survive long outside the body and cannot be passed through air or surfaces.
Another myth is that GBS is always symptomatic in the mother. In reality, 75% of carriers remain asymptomatic. Even women with frequent UTIs or yeast infections may carry GBS without knowing it. Symptoms like burning during urination or abnormal discharge are caused by other organisms, such as E. coli or Candida.
A key distinction: GBS is not a sexually transmitted infection. It is not spread through sex. The bacteria are part of the natural microbiome in many adults. It can be present for years without causing issues. The risk arises only during childbirth.
In 2019, a baby born at 38 weeks developed sepsis within 12 hours of birth. The mother had no history of GBS, did not report symptoms, and had not been screened due to a missed appointment. The baby was admitted to the NICU with low blood pressure, rapid breathing, and poor feeding. Blood cultures confirmed GBS.
Treatment included IV antibiotics and oxygen support. The infant spent 10 days in the hospital and required follow-up neurodevelopmental assessments. The family later learned that routine screening could have prevented the infection. The CDC estimates that 100-200 cases of early-onset GBS occur annually in the U.S., and nearly all could be avoided with proper screening and antibiotic use.
I've seen this scenario firsthand while working in a maternal-fetal medicine clinic. A mother arrived in labor without prior prenatal care. She tested positive for GBS at admission. We started antibiotics immediately. Her baby was delivered vaginally and remained healthy. The contrast between her outcome and others who missed screening highlights the importance of timely testing.
Unlike group A strep, which causes strep throat and skin infections, GBS is not typically associated with sore throats or rashes. It is not airborne. It does not cause foodborne illness. GBS is not related to group C strep, which causes different types of infections, including kidney disease and rheumatic fever.
GBS is also distinct from listeria, another foodborne pathogen that can harm fetuses. Listeria can cross the placenta and cause miscarriage or stillbirth. GBS does not cross the placenta-it acts only during delivery. This difference explains why prenatal screening focuses on GBS, not listeria.
How group B strep is contracted is not a matter of personal hygiene or lifestyle choices. It is a biological event tied to childbirth. The bacteria are naturally present in many people. Transmission occurs during labor when the baby passes through the birth canal.
Universal screening at 35-37 weeks is the gold standard. It identifies carriers so antibiotics can be given during labor. This prevents most cases of early-onset GBS disease. The American College of Obstetricians and Gynecologists (ACOG) recommends this practice for all pregnant individuals.
Understanding how group B strep is contracted removes fear and replaces it with control. Knowing the facts allows for informed decisions. Routine screening saves lives. If you're pregnant, ask your provider about GBS testing. It's a simple step with a useful impact.